Re: Why ‘purity’ issues?
Appreciate the response Muddy, made up or not. It takes me back to the early RSVe trials where the vaccine made lots of antibodies, just not really good ones. It sounds like maybe they are getting a mixture of good and ban spike proteins.
I hate to say this, but the story starts to make sense when you consider the drop in NA titers between the small batch phase 1/2 trials and the commercial scale Phase 3 trial. That has thrown a big red flag for me, The only saving grace for me is that it still works very well in either case, sonI don’t understand why the FDA is being so stringent. No SAEs, only mild AES. It is not like they are injecting junk into people’s arms.